Cercare Medical

What Cercare Medical does

Cercare Medical A/S is a Danish medical imaging software company that develops AI-powered perfusion imaging solutions for neurological and oncological assessment. Founded in 2013 as a spin-out from Aarhus University by Professor Kim Beuschau Mouridsen (CEO) and Mikkel Bo Hansen (CSO), the company is built on more than 20 years of research from the Center for Functionally Integrative Neuroscience (CFIN) and MINDLab. Headquartered in Aarhus, Denmark, Cercare serves neuroradiologists, stroke centers, neuro-oncology departments, and academic medical centers globally through its Cercare Medical Neurosuite (CMN) platform and its modules: CERCARE Perfusion (CT and MRI), CERCARE Stroke, CBCT Perfusion, and the Oncology Virtual Expert brain tumor segmentation module. The technology stack centers on proprietary perfusion biomarkers, including Capillary Transit Time Heterogeneity (CTH), Oxygen Extraction Fraction (OEF), and Cerebral Metabolic Rate of Oxygen (CMRO2), enabled by a proprietary Vascular Model algorithm that the company claims provides superior correspondence with T2 FLAIR follow-up imaging compared to standard SVD techniques. AI capabilities include fully automated Arterial Input Function selection, automated lesion detection and segmentation, ASPECTS scoring for large vessel occlusion, predictive analytics for stroke treatment scenarios, and brain tumor segmentation validated with a 0.82 Dice coefficient across 100 patients. The platform is vendor-agnostic, DICOM-compatible, and processes CT, CBCT, and MRI data from all major scanner manufacturers.

The company's business model combines on-premise software licensing and subscription revenue with platform-based distribution revenue through OEM partnerships. Cercare sells via direct enterprise field sales to large hospital systems and academic medical centers, and through embedded distribution arrangements with Siemens Healthineers syngo.via OpenApps, Aidoc aiOS, Viz.ai, Blackford, Arterys, Sectra Amplifier, and Wellbeing Software AI Connect. Pricing is quote-based B2B tailored to institution needs, scanner configurations, and deployment scope. The company holds CE marking under European Medical Device Regulation 2017/745, four FDA 510(k) clearances (MRI Perfusion May 2021, CT Perfusion December 2024, CBCT Perfusion May 2026, Oncology Virtual Expert K260316 June 2026), ISO 27001, DTAC, and Cyber Essentials certifications, supporting commercial activity across EMEA, North America, APAC, the Middle East, and Latin America.

Cercare has raised approximately €9.2 million in disclosed funding, comprising a €1.83 million EU SME Instrument Phase 2 grant in 2019 and a €7.4 million private round in March 2025 led by UK-based West Hill Capital to fund US, UK, and European expansion. The company reports 700+ installations across more than 20 countries, supports over 1 million diagnoses annually, and maintains a sub-1% customer churn rate. Named end customers include Karolinska University Hospital, Massachusetts General Hospital (MGH Martinos Center), Aarhus University Hospital, Fondation Rothschild Hospital, Magdeburg University Hospital, Uppsala University Hospital, Hospices Civils de Lyon, and Institut Gustave Roussy.

Name

Cercare Medical

Legal name

Cercare Medical A/S

Website

https://cercare-medical.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Cercare Medical A/S is a Danish medical imaging software company founded in 2013 that develops AI-powered perfusion imaging solutions for neuroradiology, stroke care, and neuro-oncology, serving academic medical centers and hospital systems globally through its on-premise Cercare Medical Neurosuite platform and OEM channel partnerships.

Ownership category

akta.pro rank

Product category

Medical Imaging Software (Neuroimaging AI)

NAICS

Surgical and Medical Instrument Manufacturing (339112)

akta.pro primary industry

Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)

akta.pro secondary industry

Neurology Telemedicine Platforms (HLALAGAC)

Keywords

• Perfusion imaging software
• Neurological imaging AI
• Stroke assessment software
• Brain tumor segmentation
• Medical imaging analytics

Headquarters

HQ city

Aarhus

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Licenses and Subscriptions: On-premise software licensing model for healthcare institutions including hospitals, academic medical centers, and research facilities. All devices are CE marked under European Medical Device Regulation 2017/745, with select devices FDA cleared for US market.
2. Platform Distribution: Software distributed through partner platforms including Siemens Healthineers syngo.via OpenApps, Blackford Platform, Arterys cloud platform, Viz.ai platform, and Sectra Amplifier marketplace.

Go-to-market motion4 records

Distribution channels9 records

Marketing channels8 records

Core offering

Cercare Medical develops and sells AI-powered perfusion imaging software for CT and MRI, providing automated post-processing and parametric maps for neurological and oncological assessment. The Cercare Medical Neurosuite (CMN) platform enables hospitals, stroke centers, and academic medical centers to perform advanced tissue viability analysis using unique biomarkers (CTH, OEF, CMRO2) and traditional perfusion markers. The software supports acute stroke triage, brain tumor segmentation, and neurodegenerative disease assessment through DICOM-compatible, vendor-agnostic on-premise deployment or via integration with major imaging platforms.

Product overview

Cercare Medical offers Cercare Medical Neurosuite (CMN), a comprehensive on-premise neuroimaging platform built on more than 25 years of research in perfusion imaging. The platform encompasses four core product lines: CERCARE Perfusion (for CT and MRI perfusion imaging), CERCARE Stroke (AI-powered stroke assessment), CBCT Perfusion (cone-beam CT perfusion for angio suites), and Oncology Virtual Expert (AI-powered brain tumor segmentation). The platform generates unique perfusion biomarkers including Capillary Transit Time Heterogeneity (CTH), Oxygen Extraction Fraction (OEF), Cerebral Metabolic Rate of Oxygen (CMRO2), and traditional markers (rCBF, rCBV, MTT). All solutions are fully automated via AI, vendor-agnostic with DICOM compatibility, and available through multiple distribution channels including Siemens Healthineers syngo.via, Blackford, Arterys, Viz.ai, Aidoc aiOS, Sectra Amplifier, and Wellbeing Software marketplaces.

Differentiator

Problem solved

Functional benefit

Brands

• Cercare Perfusion: Advanced, fully-automated perfusion imaging solution for CT and MRI providing high-quality parametric maps including capillary blood volume, flow, oxygen extraction, and metabolic biomarkers.
• Cercare Stroke
• Cercare Medical Neurosuite (CMN)
• Oncology Virtual Expert
• CBCT Perfusion

Products and services

• CERCARE Perfusion Advanced fully-automated perfusion imaging software for CT and MRI that generates high-quality parametric maps including traditional markers (CBF, CBV, MTT) and unique oxygen metabolism markers (CTH, OEF, CMRO2). Uses AI to automate arterial input function selection and post-processing, running on standard DICOM files with compatibility for major scanner manufacturers and PACS providers. Targets radiologists, neurologists, and oncologists at hospitals and academic medical centers.
• CERCARE Stroke AI-powered imaging analysis software for acute ischemic stroke that identifies and quantifies stroke lesions using an AI algorithm trained on previous stroke cases. Provides easy-to-read maps of suspected stroke lesion location and volumes to help assess strokes quickly and accurately for faster clinical decision-making. Targets stroke centers, neuro-interventional teams, and emergency radiology departments.
• Oncology Virtual Expert AI-powered brain tumor segmentation module designed for semi-automated tumor analysis within clinical radiology workflows. FDA 510(k) cleared (K260316), validated across 100 patients with a Dice coefficient of 0.82. Addresses data governance and HIPAA compliance requirements for U.S. health systems. Targets neuro-oncology departments, cancer hospitals, and academic medical centers.
• CBCT Perfusion Cone-beam CT perfusion technology providing real-time, automated perfusion imaging directly within the angio suite. FDA 510(k) cleared, the solution improves stroke and oncology care by eliminating delays in diagnosis and treatment, enabling clinicians to assess tissue health during procedures. Includes full set of perfusion markers (CBF, CBV, MTT), advanced oxygen metabolism imaging (OEF, CMRO2), and vendor-agnostic platform architecture. Targets neurointerventional suites and angio rooms.
• Cercare Medical Neurosuite (CMN) Comprehensive vendor-neutral neuroimaging platform encompassing all Cercare Medical products including CERCARE Perfusion, CERCARE Stroke, CBCT Perfusion, and Oncology Virtual Expert modules. Built on more than 20 years of research in perfusion imaging, the platform delivers advanced microvascular modeling and unique perfusion biomarkers for stroke, oncology, and neurodegenerative disease assessment. Features automated detection and processing, multiple imaging modalities (CTP, CTA, NCCT, DSC-MRI, DCE-MRI, DWI), and on-premise deployment for data security.

Quantifiable outcome

• Brain tumor segmentation validated with Dice coefficient of 0.82 across 100 patients
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability4 records

Feature10 records

Partnerships

Eleven partnerships are on record, tiered core and regional.

• Siemens HealthineerscoreTechnology or Integration · 27 May 2026Global collaboration on cone-beam CT perfusion technology for stroke care. Siemens Healthineers is expanding strategic collaborations in advanced imaging through partnership with Cercare Medical for cone-beam CT perfusion imaging, positioning the company to compete in precision medicine and image-guided interventions.
• AidoccoreTechnology or Integration · 16 December 2025Strategic partnership to expand Aidoc's neurosciences portfolio with Cercare's advanced MR perfusion and automated ASPECTS capabilities, fully integrated into Aidoc's aiOS enterprise operating system for clinical AI. Aims to connect fragmented neuro workflows and accelerate critical decisions across neurology, neuroradiology, neurointervention, and neurosurgery.
• Fondation Rothschild HospitalcoreStrategic or Co-development Partner · 2 February 2024Groundbreaking collaboration integrating Cercare's pioneering medical imaging software into the hospital's diagnostics and treatment services. Includes extensive training and ongoing support, transforming patient diagnostics and care.
• Viz.aicoreTechnology or Integration · 29 November 2022Global partnership agreement to incorporate Cercare Perfusion into Viz.ai's platform, enhancing the AI-powered neurovascular portfolio and broadening imaging features for institutions that perform MR imaging in patient workflows.
• ArteryscoreTechnology or Integration · 29 November 2021Cercare Perfusion made available on Arterys' cloud-based platform, offering clinicians access to fast and accurate decision support and workflow management tools in the Arterys NeuroAI suite for neuroradiology offerings.
• Massachusetts General Hospital (MGH Martinos Center)coreStrategic or Co-development Partner · 26 May 2021MGH Athinoula A. Martinos Center using CERCARE Perfusion for research on lesion progression of adrenoleukodystrophy patients. Solution provides OEF, CTH, and CMRO2 maps for subtle clues regarding future potential for lesion progression not visible on conventional MR imaging.
• Aarhus University HospitalcoreStrategic or Co-development Partner · 20 April 2021CERCARE Perfusion implemented at AUH for pilot project assessing treatment response in brain tumors. AUH is one of Denmark's 5 national super hospitals and winner of Denmark's Best Hospital 13 times in a row.
• Karolinska University HospitalcoreStrategic or Co-development Partner · 25 January 2021Contract for Karolinska to use Cercare Perfusion for clinical and research purposes. Hospital uses solution for assessment of brain perfusion scans across traditional applications and cutting-edge research, including oncology, neurodegenerative disorders, and long COVID-19 analysis.
• BlackfordcoreChannel Partner/ Reseller/ Distributor · 3 December 2020CERCARE Stroke and CERCARE Perfusion added to Blackford's curated marketplace of medical imaging AI applications. Blackford's platform approach enables simplified and accelerated implementation within healthcare institutions' existing workflows through a single integration point.
• Wellbeing SoftwareregionalChannel Partner/ Reseller/ Distributor · 6 July 2020CERCARE Stroke and CERCARE Perfusion made available to UK healthcare professionals on AI Connect Marketplace, providing NHS trusts access to AI-driven imaging solutions for acute ischemic stroke assessment and neurological disorders.
• SectraregionalChannel Partner/ Reseller/ DistributorCertified Sectra Amplifier Partner, providing access to Sectra's enterprise imaging customer base in healthcare institutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• RapidAI: RapidAI is the most direct competitor to Cercare in AI-powered CT and MR perfusion imaging for stroke and aneurysm triage, with broad hospital penetration and a similar product set spanning stroke, aneurysm, and PE. Both companies target neuroradiology and stroke centers with automated post-processing and decision support, but RapidAI is substantially larger and more commercially entrenched in the US.
• Brainomix: Brainomix (e-Stroke suite) provides AI-based imaging biomarkers for stroke assessment, including ASPECTS scoring and perfusion analysis, directly competing with CERCARE Stroke and CERCARE Perfusion in the same hospital customers. Both companies are European-headquartered AI imaging vendors targeting similar stroke workflows and clinical decision support use cases.
• Viz.ai: Viz.ai is both a partner (embeds Cercare Perfusion in its platform) and a direct competitor in AI-powered stroke care coordination and neurovascular clinical workflow. Both companies target the same acute stroke hospital customers, and Viz.ai's broader care-coordination suite creates overlap with Cercare's stroke imaging analysis.
• icometrix: icometrix provides AI-powered MRI analysis for multiple sclerosis, dementia, and other neurological disorders, overlapping with Cercare's neurodegenerative and perfusion imaging offerings. Both are European AI neuroimaging companies selling FDA-cleared and CE-marked clinical software to academic medical centers and hospitals.
• Perspectum: Perspectum develops AI-driven quantitative imaging tools for neurological and metabolic disease assessment, overlapping with Cercare's neurodegenerative and oncology perfusion analysis. Both companies serve academic medical centers with advanced imaging biomarker software grounded in peer-reviewed research.
• Quibim: Quibim provides AI-based medical image analysis for oncology and radiology, with overlap in brain tumor segmentation and quantitative imaging biomarkers relevant to Cercare's Oncology Virtual Expert. Both companies target hospital radiology departments with AI imaging analysis tools.
• Avicenna.ai: Avicenna.ai develops AI tools for radiology workflow, including stroke and pulmonary embolism detection, positioning it as a peer in clinical AI imaging with similar hospital customer profiles to Cercare. Both companies compete for AI imaging budgets in acute care settings.

Broad incumbents

• Aidoc: Aidoc is both a partner (Cercare is integrated into Aidoc's aiOS platform) and a broader clinical AI incumbent offering AI triage and workflow tools across multiple imaging specialties. While Cercare specializes in neuroimaging perfusion, Aidoc competes indirectly via its broader neurology/neuroradiology portfolio and enterprise sales reach.
• Blackford Analysis: Blackford is both a channel partner (distributes Cercare Stroke and Cercare Perfusion through its AI marketplace) and a broader AI imaging platform offering its own curation and deployment infrastructure. While Blackford's primary role is distribution rather than competing imaging analysis, it competes indirectly for AI imaging application budgets at hospitals.

Emerging players

• Incepto Medical: Incepto Medical is a European AI imaging platform curating and deploying third-party radiology AI applications, including stroke and neuroimaging tools that overlap with Cercare's portfolio. Both companies target French and European hospital systems with AI imaging solutions, though Incepto focuses on broader radiology workflow applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cercare-medical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cercare Medical